Search research articles
Contact Us
Filters
Showing results (451-460 of 457) with videos related to
Page
of 46
Sort By:
You have reached the last page of results.
This site can display upto 457 results.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Biorxiv : the Preprint Server for Biology
|
December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimic
Jung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology
|
September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapy
Jung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Cancer Discovery
|
July 8, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly, Megan T Hoffman, Laleh Abbassi, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
March 20, 2023
Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5-Year Update
William S Tierney, Li-Ching Huang, Sheau-Chiann Chen, et al.
The Annals of Otology, Rhinology, and Laryngology
|
February 25, 2021
Association of Social Determinants of Health with Time to Diagnosis and Treatment Outcomes in Idiopathic Subglottic Stenosis
Jaclyn Lee, Li-Ching Huang, Lynn D Berry, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
November 1, 2019
Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis
Alexander Gelbard, Catherine Anderson, Lynne D Berry, et al.
Page
of 46
Search research articles
Search
Showing results (451-460 of 457) with videos related to
Sort By:
Page
of 46
You have reached the last page of results.
This site can display upto 457 results.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Biorxiv : the Preprint Server for Biology
|
December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimic
Jung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology
|
September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapy
Jung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Cancer Discovery
|
July 8, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly, Megan T Hoffman, Laleh Abbassi, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
March 20, 2023
Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5-Year Update
William S Tierney, Li-Ching Huang, Sheau-Chiann Chen, et al.
The Annals of Otology, Rhinology, and Laryngology
|
February 25, 2021
Association of Social Determinants of Health with Time to Diagnosis and Treatment Outcomes in Idiopathic Subglottic Stenosis
Jaclyn Lee, Li-Ching Huang, Lynn D Berry, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
November 1, 2019
Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis
Alexander Gelbard, Catherine Anderson, Lynne D Berry, et al.
Page
of 46